Anteo Diagnostics Ltd has released a press release.
Joint Development and Sales Agreement Executed
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Full Year Results and Business Update Presentation
- FY2025 Full Year Appendix 4E and Annual Report
- Appointment of MD & CEO and Annual Staff Review Process
- Queensland Government Grant Funding Update
- $2.59 million R&D Tax Incentive received
Later from AnteoTech
- Ultranode X achieves more than 1,000 Cycles at 80% Capacity
- AnteoBind order received and Life Sciences Update
- Trading Halt
- AnteoTech $3.5m Capital Raising
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech